FISV — Fiserv, Inc.

Sentiment broke on August 6, 2026: Q2 GAAP revenue fell 4% YoY to $5.29B, adjusted EPS of $1.84 missed the $1.91 consensus, product revenue came in at $1.00B vs $1.08B expected, and management slashed full-year adjusted EPS guidance from $8.00-$8.30 to $7.20-$7.40 while resetting organic growth to (1%)-0%. Organic revenue contracted 5%, with Financial Solutions down 8% and Merchant Solutions down 1% - the latter is the tell, because Clover was the entire growth story. Wells Fargo and TD Cowen both trimmed targets, the consensus drift has moved toward Hold, and the tape reflects a collapsed multiple: as of 2026-09-13 the stock sits 11.2% below its 200-day average and 78% below the 52-week high of $238.59. The lone bullish counterweight is the +5.4% single-day move into 2026-09-13 (from $48.93 to $51.58) and a 1-month return of roughly flat, which hints at early bargain-hunting at ~8x EV/EBITDA, but that is a valuation argument, not a fundamental one.

The trend is decelerating into outright contraction, not a blip. Revenue went from $4.87B in Q3 2023 to a peak of $5.52B in Q2 2025, then stalled: $5.26B (Q3'25), $5.28B (Q4'25), $5.03B (Q1'26), $5.29B (Q2'26). YoY revenue went from +8.0% in Q2 2025 to -2.0% in Q1 2026 to -4.1% in Q2 2026. The margin damage is worse than the top line: operating income fell from $1.696B in Q2 2025 (30.7% margin) to $838M in Q1 2026 (16.7%) and $1.015B in Q2 2026 (19.2%) - a ~40% YoY decline in operating income and roughly 700bps of margin compression across four consecutive quarters (27.3% -> 22.2% -> 16.7% -> 19.2%). Diluted EPS followed: $1.86 (Q2'25) to $1.17 (Q2'26), and Q1'26 EPS of $1.07 vs $1.51 a year earlier. Free cash flow confirms it is real, not just accounting: TTM FCF of ~$3.93B (Q3'25 $1.298B + Q4'25 $1.502B + Q1'26 $0.141B + Q2'26 $0.985B) is down ~24% from ~$5.16B in the prior TTM window, with H1 2026 capex up to $956M from $814M a year earlier. One data caveat: the source table's Q2 2026 gross_profit figure ($1.015B) is identical to operating income and is clearly inconsistent with the 47.2% TTM gross margin, so I rely on operating income and the TTM margin rather than that single line. Bottom line: four quarters of sequential erosion plus a guidance reset is a structural inflection in reported results, even if part of the compression is transformation-related expense that should eventually roll off.

Cheap versus its own history on every measure, as of 2026-09-13: trailing P/E of 9.9x against a 5-year average of 30.5x, P/S of 1.32x against a 5-year average of 3.94x, P/B of 1.03x, and EV/EBITDA of ~8.0x (EV ~$53.6B = $27.5B market cap + ~$26.1B net debt, against ~$6.7B EBITDA). Forward P/E is ~7.1x on the $7.25 next-FY consensus EPS, and the trailing free cash flow yield is ~14% ($3.93B FCF / $27.5B cap). The PEG ratio of -0.76 is meaningless here because the growth denominator is negative. The honest framing: this is not a mispriced compounder at a discount, it is a de-rated cash machine whose earnings base is currently shrinking, with ROIC of 8% roughly at cost of capital - which mathematically means growth creates little or no value and the multiple can stay low indefinitely. Cheap is warranted; whether it is cheap *enough* depends entirely on whether organic growth bottoms near 0% or keeps declining.

The stock is pricing in continued deterioration, but the denominator is moving faster than the price. Between 2025 and the August 2026 cut, FY26 EPS expectations fell from $8.00-$8.30 to $7.20-$7.40 - a ~12% reduction - while the share price had already fallen 78% from its high, so the multiple compressed far more than the estimate. At $51.58 and $7.25 of forward EPS you are paying 7.1x for a business that generated $3.9B of free cash flow over the last twelve months and carries a 47% gross margin. That is a legitimate deep-value setup IF $7.20-$7.40 is a trough. The catch: the next-FY revenue consensus of $19.57B sits below the current ~$21B annualized run-rate, which implies sell-side analysts expect revenue to keep shrinking - meaning the earnings estimate itself is likely still too high. Practical playbook: trade the revision direction, not the multiple. Two consecutive quarters of stable-to-positive organic growth (or even a clear trough at 0%) is the signal; another guidance cut turns the same 7x into 8-9x on lower numbers and the value case evaporates.

As of 2026-09-13, RSI(14) sat at 48.65 - squarely neutral and, notably, never deeply oversold despite a 78% drawdown from $238.59, which tells you there was no capitulation washout and therefore no proven base. Price was 0.87% below the 20-day SMA, 1.19% below the 50-day, and 11.22% below the 200-day (which sits near $58.1 based on that spread). Returns were -2.68% over one week, +0.04% over one month, -4.09% over three months, and -9.09% over six months - the short-term chop sits inside a persistent downtrend. The +5.4% single-day pop into 2026-09-13 (from a $48.93 close) is a bounce off the 52-week low of $47.04, not a trend change. Entry-timing implication: this is a range-bound-to-down tape near the lows with the 200-day acting as overhead resistance. There is no technical reason to front-run a bottom; a sustained reclaim of the 20- and 50-day averages followed by the 200-day would be the first confirmation. All of these levels are as of 2026-09-13 and will have moved by the time this is read.

• Elevated Treasury yields and a higher-for-longer rate backdrop compress fintech/payments multiples and raise the refinancing cost on Fiserv's ~$26.7B of long-term debt (only $627M of cash on the balance sheet against it).
• Financial-institution IT budget caution: banks are delaying core-processing implementations and cross-sell decisions, which showed up directly as an 8% organic decline in the Financial Solutions segment in Q2 2026.
• SMB merchant competitive intensity from Toast, Block/Square, Stripe and Shift4 in integrated payments and point-of-sale, which stalled Clover-driven Merchant Solutions organic growth at -1% in Q2 2026.
• Sector rotation out of high-multiple technology and fintech into value/defensives, a de-rating force that has compressed Fiserv's multiple far faster than its earnings have fallen.
• Regulatory scrutiny of payment processing economics (debit routing, interchange, fee transparency) and open-banking/data-access rules, which add compliance cost and modestly pressure per-transaction pricing.
• Macro volatility in consumer spending on the SMB side - energy spikes, geopolitical tension and soft discretionary demand hit small merchant volumes, where Fiserv has outsized exposure via Clover.

• Q3 2026 earnings, expected late October 2026: the single most important data point. Investors need evidence that organic growth is stabilizing near 0% and that the FY26 guidance of $7.20-$7.40 holds rather than gets cut again.
• FY2027 guidance in February 2027: this reset is what determines whether $7.25 EPS is a genuine trough or just a waypoint on a declining curve - the whole 'cheap' thesis hangs on it.
• Execution proof on the 'One Fiserv' transformation: if the integration and restructuring charges actually roll off and savings drop to the margin, operating income can re-expand even on flat revenue, which would be a powerful re-rating trigger.
• Further investor/tech conference appearances by CEO Takis Georgakopoulos and CFO Paul Todd defending medium-term targets and Clover's adoption trajectory - management credibility is currently a live variable, not a given.
• Capital return: with ~$3.9B of trailing free cash flow against a $27.5B market cap, aggressive buybacks at 7x earnings are highly accretive per share if cash flow holds - a self-help catalyst the market is currently ignoring.
• Potential portfolio action (divestiture, carve-out, or restructuring of the underperforming Financial Solutions assets) that would simplify the story and let the market value Clover separately.

• This may be structural decline rather than cyclical softness: Financial Solutions organic revenue of -8% signals real pressure on the legacy bank core-processing franchise, and Merchant Solutions at -1% shows Clover has lost the momentum that justified the old 30x multiple.
• Leverage is meaningful: long-term debt of $26.68B against only $627M of cash on the 2026-06-30 balance sheet, with GAAP-derived EBITDA of ~$6.7B, puts net debt at roughly 3.9x - if EBITDA keeps falling, credit terms and refinancing get harder exactly when the business can least afford it.
• Earnings quality: Q2 2026 GAAP EPS of $1.17 versus adjusted EPS of $1.84 is a ~57% gap driven by recurring 'transformation' and integration charges. If those costs are permanent rather than one-off, the forward EPS base the cheap multiple rests on is overstated.
• Analyst next-FY revenue consensus of $19.57B implies further contraction from the ~$21B annualized 2026 run-rate, meaning the earnings estimate has room to come down again - the classic value-trap mechanism.
• ROIC of 8% against a likely ~8-9% cost of capital means growth is roughly value-neutral today; without a credible path to higher returns, the stock can stay cheap for years regardless of how optically attractive the multiple looks.
• Management and credibility risk: a new CEO/CFO pair mid-way through a messy restructuring that has already missed, with a track record of guiding high and cutting, invites continued multiple compression on any further stumble.

Fiserv is a genuine cash machine with a broken story, and the market has repriced it accordingly - $3.9B of trailing free cash flow, a ~14% FCF yield, ~8x EV/EBITDA and 1.03x book against a business that just guided organic growth to (1%)-0% and cut full-year EPS by 12%. The deep-value setup is real, but so is the evidence of structural erosion (Financial Solutions -8% organic, four straight quarters of margin compression, 8% ROIC at roughly cost of capital), which is why I would not call this a buy at $51.58. This is a turnaround bet requiring proof, and the proof does not exist yet - the next two quarterly prints either show organic growth bottoming near zero (in which case the current price is meaningfully too low) or confirm the estimate base is still too high (in which case the 'cheap' multiple is an illusion). Size accordingly, or wait for the October 2026 print.

Blended 55/45 of two legs. (1) Forward earnings: I haircut management's $7.20-$7.40 FY26 adjusted EPS guide to ~$6.90 of sustainable cash EPS to reflect the recurring nature of transformation charges, and apply a 10.0x multiple - below the 11-13x the market pays no-growth processors, above the ~7x Fiserv trades at - producing $69.00. (2) Free cash flow: normalized FCF of ~$3.8B on ~533M shares = $7.13/share, capitalized at a 12.5% required yield (justified by 3.9x net leverage, negative organic growth and 8% ROIC) = $57.00. Weighted result $63.60, which sits above the current $51.58 and roughly in line with the $62.46 sell-side consensus average but well below the $91 high target. The bear case (EBITDA erodes to ~$6.2B and stays at 8x) implies ~$40; the bull case (stabilization plus a return to mid-single-digit growth at 11x EBITDA) implies ~$90 - the spread is wide because the single swing factor is whether organic growth bottoms at 0% or keeps falling.